How old is this mutation? - A study of three Ashkenazi Jewish founder mutations

BMC Genetics

Volumn 11, Issue , 2010, Pages

  Greenwood, Celia M T ^a,b   Sun, Shuying ^c   Veenstra, Justin ^d   Hamel, Nancy ^e   Niell, Bethany ^f   Gruber, Stephen ^g   Foulkes, William D ^e,h,i  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^h MCGILL UNIVERSITY   (Canada)

ⁱ MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; BRCA2 PROTEIN; PROTEIN MSH2; MSH2 PROTEIN, HUMAN;

ARTICLE; BREAST CANCER; COLORECTAL CANCER; CONTROLLED STUDY; FOUNDER EFFECT; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC DATABASE; GENETIC RECOMBINATION; GENETIC VARIABILITY; GENOTYPE; GOLDGAR METHOD; GROWTH RATE; HAPLOTYPE; HUMAN; INTRA ALLELIC COALESCENT MODEL; JEW; MAJOR CLINICAL STUDY; METHODOLOGY; MUTATIONAL ANALYSIS; SENSITIVITY ANALYSIS; SINGLE MARKER METHOD; GENETIC PREDISPOSITION; GENETICS; MUTATION; STATISTICAL MODEL; TIME; TUMOR SUPPRESSOR GENE;

FOUNDER EFFECT; GENE FREQUENCY; GENES, APC; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JEWS; MODELS, STATISTICAL; MUTATION; MUTS HOMOLOG 2 PROTEIN; TIME;

EID: 77954165930     PISSN: None     EISSN: 14712156     Source Type: Journal    
DOI: 10.1186/1471-2156-11-39     Document Type: Article

References (25)

1. Risch N, Tang H, Katzenstein H, Ekstein J. Geographic Distribution of Disease Mutations in the Ashkenazi Jewish Population Supports Genetic Drift over Selection. Am J Hum Genet 2003, 72:812-822. 10.1086/373882, 1180346, 12612865.
2. Ellis NA, Kirchhoff T, Mitra N, Ye TZ, Chuai S, Huang H, Nafa K, Norton L, Neuhausen S, Gordon D, Struewing JP, Narod S, Offit K. Localization of breast cancer susceptibility loci by genome-wide SNP linkage disequilibrium mapping. Genet Epidemiol 2006, 30:48-61. 10.1002/gepi.20101, 16206141.
3. Rubinstein W. Hereditary breast cancer in Jews. Familial Cancer 2004, 3:249-257. 10.1007/s10689-004-9550-2, 15516849.
4. Foulkes WD, Thiffault I, Gruber SB, Horwitz M, Hamel N, Lee C, Shia J, Markowitz A, Figer A, Friedman E, Farber D, Greenwood CM, Bonner JD, Nafa K, Walsh T, Marcus V, Tomsho L, Gebert J, Macrae FA, Gaff CL, Paillerets BB, Gregersen PK, Weitzel JN, Gordon PH, MacNamara E, King MC, Hampel H, De La Chapelle A, Boyd J, Offit K, Rennert G, Chong G, Ellis NA. The founder mutation MSH2z.ast;1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. Am J Hum Genet 2002, 71:1395-412. 10.1086/345075, 420003, 12454801.
5. Niell BA, Long JC, Rennert G, Gruber SB. Genetic Anthropology of the Colorectal Cancer-Susceptibility Allele APC I1307K: Evidence of Genetic Drift within the Askenazim. Am J Hum Genet 2003, 73:1250-1260. 10.1086/379926, 1180391, 14624392.
6. Risch N, de Leon D, Ozelius L, Kramer P, Almasy L, Singer B, Fahn S, Breakfield X, Bressman S. Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population. Nat Genet 1995, 9:152-159. 10.1038/ng0295-152, 7719342.
7. Ostrer H. A genetic profile of contemporary Jewish populations. Nature Reviews Genetics 2001, 2:891-898. 10.1038/35098506, 11715044.
8. Need AC, Kasperavičiūtė D, Cirulli ET, Goldstein DB. A genome-wide genetic signature of Jewish ancestry perfectly separates individuals with and without full Jewish ancestry in a large random sample of European Americans. Genome Biology 2009, 10:R7. (doi:10.1186/gb 2009-10-1-r7), 10.1186/gb-2009-10-1-r7, 2687795, 19161619.
9. Serre JL, Simon-Bouy B, Mornet E, Jaume-Roig B, Balassopoulou A, Schwartz M, Taillandier A, Boué J, Boué A. Studies of RFLP closely linked to the cystic fibrosis locus throughout Europe lead to new considerations in populations genetics. Hum Genet 1990, 84:449-54. 10.1007/BF00195818, 1969843.
10. Slatkin M, Rannala B. Estimating allele age. Annual Review of Genomics and Human Genetics 2000, 01:225-249.
11. Labuda M, Labuda D, Korab-Laskowska M, Cole DEC, Ziet-kiewicz E, Weissexnbach J, Popowska E, Pronicka E, Root AW, Glorieux FH. Linkage disequilibrium analysis in young populations: pseudo-vitamin D-deficiency rickets and the founder effect in French Canadian. Am J Hum Genet 1996, 59:633-643. 1914903, 8751865.
12. Neuhausen SL, Mazoyer S, Friedman L, Stratton M, Offit K, Caligo A, Tomlinson G, Cannon-Albright L, Bishop T, Kelsell D, Solomon E, Weber B, Couch F, Struewing J, Tonin P, Durocher F, Narod S, Skolnick MH, Lenoir G, Serova O, Ponder B, Stoppa-Lyonnet D, Easton D, King MC, Goldgar DE. Haplotype and Phenotype Analysis of Six Recurrent BRCA1 mutation in 61 families: Results of an International study. Am J Hum Genet 1996, 58:271-280. 1914544, 8571953.
13. Neuhausen SL, Godwin AK, Gershoni-Baruch R, Schubert E, Garber J, Stoppa-Lyonnet D, Olah E, Csokay B, Serova O, Lalloo F, Osorio A, Stratton M, Offit K, Boyd J, Caligo MA, Scott RJ, Schofield A, Teugels E, Schwab M, Cannon-Albright L, Bishop T, Easton D, Benitez J, King MC, Ponder BA, Weber B, Devilee P, Borg A, Narod SA, Goldgar D. Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: Results of an international study. Am J Hum Genet 1998, 62:1381-1388. 10.1086/301885, 1377164, 9585613.
14. Rannala B, Slatkin M. Likelihood analysis of disequilibrium mapping, and related problems. Am J Hum Genet 1998, 62:459-73. 10.1086/301709, 1376885, 9463316.
15. Rannala B, Reeve J. High-resolution multipoint linkage-disequilibrium mapping in the context of human genome sequence. Am J Hum Genet 2001, 69:159-178. 10.1086/321279, 1226031, 11410841.
16. Reeve J, Rannala B. DMLE+: Bayesian linkage disequilibrium gene mapping. Bioinformatics 2002, 18:894-895. 10.1093/bioinformatics/18.6.894, 12075030.
17. Sun S, Greenwood CMT, Thiffault I, Hamel N, Chong G, Foulkes WD. The HNPCC associated MSH2&1906G->C founder mutation probably originated between 1440CE and 1715 CE in the Ashkenazi Jewish population. J Med Genet 2005, 42:766-8. 10.1136/jmg.2005.030999, 1735921, 16199548.
18. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001, 68:978-989. 10.1086/319501, 1275651, 11254454.
19. Stephens M, Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population. Am J Hum Genet 2003, 73:1162-1169. 10.1086/379378, 1180495, 14574645.
20. Stephens M, Scheet P. Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. American Journal of Human Genetics 2005, 76:449-462. 10.1086/428594, 1196397, 15700229.
21. Shtoyerman-Chen R, Friedman E, Figer A, Carmel M, Patael Y, Rath P, Fidder HH, Bar-Meir S, Theodor L. The I1307K APC polymorphism: prevalence in non-ashkenazi Jews and evidence for a founder effect. Genetic Testing 2001, 5:141-146. 10.1089/109065701753145628, 11551102.
22. Struewing P, Coriaty ZM, Ron E, Livoff A, Konichezky M, Cohen P, Resnick MB, Lifzchiz-Mercerl B. Founder BRCA1/2 mutations among male patients with breast cancer in Israel. Am J Hum Genet 1999, 65:1800-1801. 10.1086/302678, 1288396, 10577940.
23. Wilson IJ, Weale ME, Balding DJ. Inferences from DNA data: population histories, evolutionary processes and forensic match probabilities. J R Statist Soc A 2003, 166(Part 2):155-201.
24. Marroni F, Cipollini G, Peissel B, D'Andrea E, Pensabene M, Radice P, Caligo MA, Presciuttini S, Bevilacqua G. Reconstructing the genealogy of a BRCA1 founder mutation by phylogenetic analysis. Ann Hum Genet 2008, 72:310-8. 10.1111/j.1469-1809.2007.00420.x, 18215206.
25. Clendenning M, Baze ME, Sun S, Walsh K, Liyanarachchi S, Fix D, Schunemann V, Comeras I, Deacon M, Lynch JF, Gong G, Thomas BC, Thibodeau SN, Lynch HT, Hampel H, de la Chapelle A. Origins of prevalence of the American Founder Mutation of MSH2. Cancer Research 2008, 68:2145-53. 10.1158/0008-5472.CAN-07-6599, 18381419.